Cargando…
Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome
Autores principales: | Madera-Acosta, Adria, Johnson-Wall, Helen, Carbone, Laura D, Meszaros, Adam, Berman, Adam E, White, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962723/ https://www.ncbi.nlm.nih.gov/pubmed/33748661 http://dx.doi.org/10.1093/rap/rkab010 |
Ejemplares similares
-
The Spectrum of Extraglandular Manifestations in Primary Sjögren’s Syndrome
por: Mihai, Ancuta, et al.
Publicado: (2023) -
Extraglandular ocular involvement and morbidity and mortality in primary Sjögren’s Syndrome
por: Mathews, Priya M., et al.
Publicado: (2020) -
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
por: Rose, Thomas, et al.
Publicado: (2016) -
Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022) -
Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020)